VITALE, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 520
EU - Europa 242
AS - Asia 169
SA - Sud America 7
OC - Oceania 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 949
Nazione #
US - Stati Uniti d'America 518
UA - Ucraina 105
CN - Cina 98
SG - Singapore 54
DE - Germania 36
IT - Italia 33
SE - Svezia 16
FI - Finlandia 15
BE - Belgio 12
GB - Regno Unito 12
BR - Brasile 7
CZ - Repubblica Ceca 5
KR - Corea 5
AU - Australia 4
IN - India 3
TR - Turchia 3
CA - Canada 2
CI - Costa d'Avorio 2
ES - Italia 2
EU - Europa 2
LU - Lussemburgo 2
MA - Marocco 2
BD - Bangladesh 1
FR - Francia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 949
Città #
Chandler 138
Jacksonville 65
Ann Arbor 53
Princeton 36
Singapore 34
Nanjing 29
Dearborn 27
Sassari 21
New York 14
Wilmington 13
Brussels 12
Beijing 9
Ashburn 8
Boardman 8
Nanchang 8
Woodbridge 8
Changsha 7
Jinan 5
Seoul 5
Brno 4
Hebei 4
Jiaxing 4
San Francisco 4
Santa Clara 4
Tianjin 4
Zhengzhou 4
Andover 3
Guangzhou 3
Hangzhou 3
Izmir 3
Kunming 3
Munich 3
San Mateo 3
Shenyang 3
Abidjan 2
Cagliari 2
Canberra 2
Fuzhou 2
Hefei 2
Lanzhou 2
Luxembourg 2
Monmouth Junction 2
Norwalk 2
Rome 2
São Paulo 2
Toronto 2
Andijan 1
Augusta 1
Bom Jesus 1
Carapicuíba 1
Changchun 1
Charleston 1
Chicago 1
Chisinau 1
Contagem 1
Dallas 1
Dhaka 1
Ferraz de Vasconcelos 1
Houston 1
Islamabad 1
Juiz de Fora 1
Leawood 1
Los Angeles 1
Madrid 1
Melbourne 1
Mumbai 1
New Delhi 1
Newark 1
Ningbo 1
Paris 1
Riyadh 1
Stockholm 1
Sydney 1
Taizhou 1
Tauranga 1
Tel Aviv 1
Ussana 1
Vientiane 1
Zhoushan 1
Totale 609
Nome #
Synthesis and in vitro antitumor activity of new quinoxaline derivatives 85
2-Arylbenzimidazoles as Antiviral and Antiproliferative Agents-Part 2 83
2-Arylbenzimidazoles as Antiviral and Antiproliferative Agents-Part 1 69
4-Substituted anilino Imidazo[1,2-a] and triazolo[4,3-a]quinoxalines. Synthesis and evaluation of in vitro biological activity 65
5,7-Dinitro and 5,7-diamino-3-phenyl-2-aminobenzylquinoxalines as novel analogues of antifolate agents Methotrexate and Trimetrexate 61
Quinoline tricyclic derivatives. Design, synthesis and preliminary in vitro and in silico antiviral activity against flaviridae family of three new classes of virus encoded RNA- dependent polymerase(RdRp). In: Book of Abstracts 59
2-Arilbenzimidazoli come potenziali agenti antivirali e antitumorali 57
The first meeting of the European Register of Cystic Echinococcosis (ERCE) 55
Quinoxaline derivatives as new inhibitors of coxsackievirus B5 54
New models of 2-styrylbenzimidazoles as potential antiviral and anticancer agents 51
5-Acetyl-2-arylbenzimidazoles as antiviral agents. Part 4. 51
Development of folates analogs against folate-dependent enzymes 49
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells 46
2-Arilbenzimidazoli come potenziali agenti antivirali e antitumorali 40
Quinoline triciclic derivatives. Design, synthesis and preliminary in vitro and in silico antiviral activity against flaviviridae family of three new classes of viruses-encoded RNA-dependent RNA polymerase (RdRp) inhibitors 37
Styrylbenzimidazoles. Synthesis and biological activity. Part 3 37
2-arilbenzimidazoli come potenziali agenti antivirali e antitumorali 28
Analoghi chinossalinici omologhi del thymitaq e 2-(ariltio)chinossaline analoghe del trimetrexato e del metotrexato 25
Totale 952
Categoria #
all - tutte 4.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 0 0 18 29 47 2 19 9 19 2
2020/2021136 18 2 19 1 19 2 17 7 16 18 16 1
2021/202294 13 3 0 1 4 0 4 9 5 8 13 34
2022/2023248 20 36 6 44 27 29 0 25 44 2 11 4
2023/202470 11 8 1 1 8 14 9 0 0 0 7 11
2024/202588 3 5 31 18 31 0 0 0 0 0 0 0
Totale 952